Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
about
Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsComparison of hepatocellular carcinoma in Eastern versus Western populations.Evaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and fisher information analysis.Reduced red blood cell count predicts poor survival after surgery in patients with primary liver cancer.Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma.Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular CarcinomaRecurrence of Hepatocellular Carcinoma With Epithelial-Mesenchymal Transition After Spontaneous Regression: A Case Report.Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy.Staging systems for hepatocellular carcinoma: Current status and future perspectivesCurrent management of hepatocellular carcinoma: an Eastern perspective.Validation and ranking of seven staging systems of hepatocellular carcinoma.The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application.Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects.Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
P2860
Q26743666-35B58B2A-1D4F-4EDD-A0D6-FEC1EDCC9971Q30245396-A76A94E5-1007-4CFD-94C0-299686B495DDQ35298123-EFE0602A-CC15-4A66-8D44-03D270346849Q36009475-F5B15A16-B466-4200-B9FF-7AC225256ECBQ36151130-0DE73AD2-94B8-429F-808D-37E8542FDAA6Q36194925-AD2052C7-D38E-4ED3-B1F4-B9ADC7F637E2Q36196567-1C4F5055-F808-463F-A81A-924169A78913Q37629064-ACE2726F-6EDD-4DE7-A782-C4C400EE2F82Q38408876-A72D1A74-BFAF-4B9B-A32D-F40625F444D1Q38410816-451E5962-8819-4241-A117-D15A85004392Q38686026-437A528D-76ED-4F73-B220-CB16C85D5207Q41112075-CC9A8D1F-2D17-4851-A198-3137BD2F71D3Q41118461-46FE6630-AB94-41A0-9DF1-A6D942A10EF6Q41381630-5C2085AA-BC00-4B6B-9133-AA9E476615B1Q42386335-604B8331-3C8C-4ED5-BE4C-9ECB05E2DD92Q53824047-4C96A199-7358-4BF8-9C1B-4ABAD396F2D2
P2860
Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prognosis of unresectable hepa ...... JIS, CIS) in a Chinese cohort.
@ast
Prognosis of unresectable hepa ...... JIS, CIS) in a Chinese cohort.
@en
type
label
Prognosis of unresectable hepa ...... JIS, CIS) in a Chinese cohort.
@ast
Prognosis of unresectable hepa ...... JIS, CIS) in a Chinese cohort.
@en
prefLabel
Prognosis of unresectable hepa ...... JIS, CIS) in a Chinese cohort.
@ast
Prognosis of unresectable hepa ...... JIS, CIS) in a Chinese cohort.
@en
P2093
P2860
P1433
P1476
Prognosis of unresectable hepa ...... JIS, CIS) in a Chinese cohort
@en
P2093
Chun-yi Xie
Fang-jian Jiang
Jin-feng Zhang
Xi-hong Jin
Zhi-jun Shu
P2860
P304
P356
10.1371/JOURNAL.PONE.0088182
P407
P577
2014-03-07T00:00:00Z